What's new with enteroviral infections?
Nigrovic
L E
LE
Boston Combined Residency Program in Pediatrics, Massachusetts, USA. nigrovic_1@a1.tch.harvard.edu
D000998:Antiviral Agents / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004196:Disease Outbreaks; D004769:Enterovirus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000821:virology; D006801:Humans; D010069:Oxadiazoles / Q000627:therapeutic use*; D010080:Oxazoles; D016133:Polymerase Chain Reaction / Q000191:economics / Q000379:methods; D012383:Romania / Q000453:epidemiology; D012606:Scotland / Q000453:epidemiology
D000998:Antiviral Agents; D010069:Oxadiazoles; D010080:Oxazoles; C115201:pleconaril